Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Population Diagnostics names new CTO

This article was originally published in Clinica

Executive Summary

Personalised medicine firm Population Diagnostics has appointed Peggy Eis chief technology officer. Dr Eis will have a "pivotal role" in the commercialisation of the company's DNA-based tests which identify rare, causative genetic biomarkers for diseases including autism, Parkinson's and Alzheimer's. The Melville, New York firm, which was founded in 2006, is also developing companion diagnostics to predict the efficacy and safety of targeted drugs. Dr Eis has 15 years of experience in genomics research, product and business development, and marketing. She most recently worked for Roche NimbleGen as senior director of genome variation, and was previously head of the comparative genomic hybridisation microarray group at NimbleGen Systems, which was acquired by Roche.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT045225

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel